Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Opioid Use Disorder Marketed and Pipeline Drugs Report Overview
Opioid Use Disorder is a chronic neurological disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs and prolonged self-administration of opioid drugs. As the brain adapts to prolonged opioid use, the patient’s tolerance increases, so a higher dose of opioid is needed to stimulate the mesolimbic system in the same way as the original dose.
The Opioid Use Disorder marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing, and reimbursement, late-to-mid-stage pipeline products with phase transition success rate (PTSR), and the likelihood of approval (LoA) for Opioid Use Disorder (OUD). The report also analyzes the clinical and commercial landscapes of opioid use disorder and provides an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Opioid Use Disorder Marketed Drugs Segmentation by Mechanisms of Action
The key mechanisms of action for Opioid Use Disorder marketed drugs are receptor agonist and receptor antagonist. The market is dominated by receptor agonist.
Opioid Use Disorder Marketed Drugs Analysis, by Mechanisms of Action, 2023 (%)
For more MoA insights into the Opioid Use Disorder marketed drugs market, download a free report sample
Opioid Use Disorder Marketed Drugs Segmentation by Routes of Administration
The key routes of administration for Opioid Use Disorder marketed drugs are oral, injection, topical, and suppository. The most widely marketed drugs available for treating Opioid Use Disorder are oral drugs, followed by injectable therapies.
Opioid Use Disorder Marketed Drugs Analysis, by Routes of Administration, 2023 (%)
For more RoA insights into the Opioid Use Disorder marketed drugs market, download a free report sample
Opioid Use Disorder Pipeline Drugs Segmentation by Mechanisms of Action
The key mechanisms of action for Opioid Use Disorder pipeline drugs are receptor agonist, receptor antagonist, enzyme inhibitor, ion channel blocker, transporter inhibitor, and ion channel inhibitor. The Opioid Use Disorder pipeline is dominated by receptor agonists, such as mu-type opioid receptor agonists, followed by receptor antagonists, including cannabinoid receptor 1 antagonists, cannabinoid receptor 2 antagonists, and Kappa-type opioid receptor antagonists.
Opioid Use Disorder Pipeline Drugs Analysis, by Mechanisms of Action, 2023 (%)
For more MoA insights into the Opioid Use Disorder pipeline drugs market, download a free report sample
Opioid Use Disorder Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for Opioid Use Disorder pipeline drugs are oral, injection, topical, and inhalational. The majority of pipeline drugs for Opioid Use Disorder are oral drugs, followed by injectables.
Opioid Use Disorder Pipeline Drugs Analysis, by Routes of Administration, 2023 (%)
For more RoA insights into the Opioid Use Disorder pipeline drugs market, download a free report sample
Opioid Use Disorder Pipeline Drugs Segmentation by Molecule Type
The key molecule types for Opioid Use Disorder pipeline drugs are small molecule and biologic. Majority of the Opioid Use Disorder pipeline drugs are accounted for by small molecules.
Opioid Use Disorder Pipeline Drugs Analysis, by Molecule Types, 2023 (%)
For more molecule type insights into the Opioid Use Disorder pipeline drugs market, download a free report sample
Top Sponsors in the Opioid Use Disorder Marketed and Pipeline Drugs Market
Some of the top sponsors in the Opioid Use Disorder marketed and pipeline drugs market are New York State Psychiatric Institute, Yale University, John Hopkins University, Indivior Plc, University of Pennsylvania, Alkermes Plc, National Institute on Drug, Friends Research Institute Inc., Shahid Beheshti University of Medical Sciences, and Brigham and Women’s Hospital. Among commercial sponsors, Indivior has sponsored the highest number of clinical trials over the past 10 years.
Opioid Use Disorder Marketed Drugs Market Report Overview
Key Mechanisms of Action | Receptor Agonist, and Receptor Antagonist |
Key Routes of Administration | Oral, Injection, Topical, and Suppository |
Opioid Use Disorder Pipeline Drugs Market Report Overview
Key Mechanisms of Action | Receptor Agonist, Receptor Antagonist, Enzyme Inhibitor, Ion Channel Blocker, Transporter Inhibitor, and Ion Channel Inhibitor |
Key Routes of Administration | Oral, Injection, Topical, and Inhalational |
Key Molecule Types | Small Molecule and Biologic |
Top Sponsors (Marketed and Pipeline Drugs) | New York State Psychiatric Institute, Yale University, John Hopkins University, Indivior Plc, University of Pennsylvania, Alkermes Plc, National Institute on Drug, Friends Research Institute Inc., Shahid Beheshti University of Medical Sciences, and Brigham and Women’s Hospital |
Segments Covered in the Report
Opioid Use Disorder Marketed Drugs Market Mechanisms of Action Outlook (Number of Drugs)
- Receptor Agonist
- Receptor Antagonist
Opioid Use Disorder Marketed Drugs Market Routes of Administration Outlook (Number of Drugs)
- Oral
- Injection
- Topical
- Suppository
Opioid Use Disorder Pipeline Drugs Market Mechanisms of Action Outlook (Number of Drugs)
- Receptor Agonist
- Receptor Antagonist
- Enzyme Inhibitor
- Ion Channel Blocker
- Transporter Inhibitor
- Ion Channel Inhibitor
Opioid Use Disorder Pipeline Drugs Market Routes of Administration Outlook (Number of Drugs)
- Oral
- Injection
- Topical
- Inhalational
Opioid Use Disorder Pipeline Drugs Market Molecule Types Outlook (Number of Drugs)
- Small Molecule
- Biologic
Scope
GlobalData’s Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Opioid Use Disorder market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Opioid Use Disorder market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the key mechanisms of action for Opioid Use Disorder pipeline drugs?
The key mechanisms of action in the Opioid Use Disorder pipeline drugs market are receptor agonist, receptor antagonist, enzyme inhibitor, ion channel blocker, transporter inhibitor, and ion channel inhibitor.
-
What are the key routes of administration for Opioid Use Disorder pipeline drugs?
The key routes of administration in the Opioid Use Disorder pipeline drugs market are oral, injection, topical, and inhalational.
-
What are the key molecule types for Opioid Use Disorder pipeline drugs?
The key molecule types in the Opioid Use Disorder pipeline drugs market are small molecule and biologic.
-
Who are the top sponsors for Opioid Use Disorder marketed and pipeline drugs market?
Some of the top sponsors for the Opioid Use Disorder marketed and pipeline drugs market are New York State Psychiatric Institute, Yale University, John Hopkins University, Indivior Plc, University of Pennsylvania, Alkermes Plc, National Institute on Drug, Friends Research Institute Inc., Shahid Beheshti University of Medical Sciences, and Brigham and Women’s Hospital.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.